Pfizer India hiving off older drugs

Pfizer India is said to be planning a major reorganization of its product portfolio with the intention of hiving off older, lower-volume drugs either for co-marketing with Indian companies or selling them altogether. Following this operation, the firm will finalize a list of products from its US parent for launch in India over the next few years. Pfizer India recently introduced the antidepressant Zoloft (certraline) under the brand name Taxid.

Although the affected products have not been named, it is believed by Indian sources that the products to be shed will include the antibiotic terramycin and the anti-tuberculosis drug Isonex. Pfizer India is reportedly already negotiating with local companies as partners for the proposed co-marketing activities.